The biggest increase in 2-year survival associated with Medicaid expansion was among patients with stage III disease, with a ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

A s the annual Medicare open enrollment period unfolds, millions of Americans are evaluating their healthcare options for the ...

New research published online-ahead-of-print in Journal of the National Comprehensive Cancer Network found that people with ...

Conservative planning and continued business growth helped Molina keep an ongoing mismatch between payment rates and member ...

The Medicaid budget survey for fiscal years 2024 and 2025 revealed state predictions are expecting a decline in Medicaid ...

The presidential election, loss of higher federal funding, inflationary pressures and other challenges are leaving state ...

The Medicaid rate hike will mitigate headwinds in that line of Molina Healthcare's business, which has seen higher costs ...

A decrease appeared to end this summer as enrollment was virtually unchanged in July and slightly increased in August. But ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Doctors worry that Medicaid limits on addiction drug dosing could drive some patients back toward the drugs they're trying to ...

Medicaid expansion improved 2-year survival rates and access to guideline-concordant treatment for patients with HR-negative ...